223 related articles for article (PubMed ID: 32127519)
1. Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia.
Schmaelter AK; Labopin M; Socié G; Itälä-Remes M; Blaise D; Yakoub-Agha I; Forcade E; Cornelissen J; Ganser A; Beelen D; Labussière-Wallet H; Passweg J; Savani BN; Schmid C; Nagler A; Mohty M
Blood Cancer J; 2020 Mar; 10(3):26. PubMed ID: 32127519
[TBL] [Abstract][Full Text] [Related]
2. Comparable outcomes post allogeneic hematopoietic cell transplant for patients with de novo or secondary acute myeloid leukemia in first remission.
Michelis FV; Atenafu EG; Gupta V; Kim DD; Kuruvilla J; Lipton JH; Loach D; Seftel MD; Uhm J; Alam N; Lambie A; McGillis L; Messner HA
Bone Marrow Transplant; 2015 Jul; 50(7):907-13. PubMed ID: 25822226
[TBL] [Abstract][Full Text] [Related]
3. Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study.
Sengsayadeth S; Labopin M; Boumendil A; Finke J; Ganser A; Stelljes M; Ehninger G; Beelen D; Niederwieser D; Blaise D; Dreger P; Mufti G; Chevallier P; Mailhol A; Gatwood KS; Gorin N; Esteve J; Ciceri F; Baron F; Schmid C; Giebel S; Mohty M; Savani BN; Nagler A
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1406-1414. PubMed ID: 29678639
[TBL] [Abstract][Full Text] [Related]
4. Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT.
Nagler A; Labopin M; Blaise D; Raiola AM; Corral LL; Bramanti S; Sica S; Kwon M; Koc Y; Pavlu J; Kulagin A; Busca A; Rodríguez AB; Reményi P; Schmid C; Brissot E; Sanz J; Bazarbachi A; Giebel S; Ciceri F; Mohty M
J Hematol Oncol; 2023 May; 16(1):58. PubMed ID: 37248463
[TBL] [Abstract][Full Text] [Related]
5. Haploidentical transplantation outcomes for secondary acute myeloid leukemia: Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) study.
Li Z; Labopin M; Ciceri F; Blaise D; Tischer J; Ehninger G; Van Lint MT; Koc Y; Santarone S; Forcade E; Castagna L; Polge E; Mailhol A; Ruggeri A; Mohty M; Savani BN; Nagler A
Am J Hematol; 2018 Jun; 93(6):769-777. PubMed ID: 29536560
[TBL] [Abstract][Full Text] [Related]
6. Measurable residual disease, conditioning regimen intensity, and age predict outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first remission: A registry analysis of 2292 patients by the Acute Leukemia Working Party European Society of Blood and Marrow Transplantation.
Gilleece MH; Labopin M; Yakoub-Agha I; Volin L; Socié G; Ljungman P; Huynh A; Deconinck E; Wu D; Bourhis JH; Cahn JY; Polge E; Mohty M; Savani BN; Nagler A
Am J Hematol; 2018 Sep; 93(9):1142-1152. PubMed ID: 29981272
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT).
Poiré X; Labopin M; Maertens J; Yakoub-Agha I; Blaise D; Ifrah N; Socié G; Gedde-Dhal T; Schaap N; Cornelissen JJ; Vigouroux S; Sanz J; Michaux L; Esteve J; Mohty M; Nagler A
J Hematol Oncol; 2017 Jan; 10(1):20. PubMed ID: 28100265
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCC.
Malard F; Labopin M; Cho C; Blaise D; Papadopoulos EB; Passweg J; O'Reilly R; Forcade E; Maloy M; Volin L; Castro-Malaspina H; Hicheri Y; Jakubowski AA; Orvain C; Giralt S; Mohty M; Nagler A; Perales MA
J Hematol Oncol; 2018 Oct; 11(1):127. PubMed ID: 30342553
[TBL] [Abstract][Full Text] [Related]
9. Impact of postremission consolidation chemotherapy on outcome after reduced-intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia in first complete remission: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Yeshurun M; Labopin M; Blaise D; Cornelissen JJ; Sengeloev H; Vindelov L; Kuball J; Chevallier P; Craddock C; Socie G; Bilger K; Schouten HC; Fegueux N; Goker H; Maertens J; Bunjes D; Arnold R; Nagler A; Mohty M
Cancer; 2014 Mar; 120(6):855-63. PubMed ID: 24338939
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of Intermediate Risk Karyotype Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared With Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-score Adjusted Analysis.
Limvorapitak W; Barnett MJ; Hogge DE; Forrest DL; Nevill TJ; Narayanan S; Power MM; Nantel SH; Broady R; Song KW; Toze CL; Mourad YA; Sutherland HJ; Gerrie AS; White J; Sanford DS
Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):e481-e491. PubMed ID: 30100330
[TBL] [Abstract][Full Text] [Related]
11. Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT.
Nagler A; Ngoya M; Galimard JE; Labopin M; Kröger N; Socié G; Gedde-Dahl T; Potter V; Schroeder T; Platzbecker U; Ganser A; Blaise D; Salmenniemi U; Maertens J; Craddock C; Labussière-Wallet H; Yakoub-Agha I; Savani B; Mohty M
Bone Marrow Transplant; 2022 Dec; 57(12):1788-1796. PubMed ID: 36114249
[TBL] [Abstract][Full Text] [Related]
12. Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patients.
Schmälter AK; Ngoya M; Galimard JE; Bazarbachi A; Finke J; Kröger N; Bornhäuser M; Stelljes M; Stölzel F; Tischer J; Schroeder T; Dreger P; Blau IW; Savani B; Giebel S; Esteve J; Nagler A; Schmid C; Ciceri F; Mohty M
Blood Cancer J; 2024 May; 14(1):76. PubMed ID: 38697960
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic hematopoietic cell transplantation for adult patients with treatment-related acute myeloid leukemia during first remission: Comparable to de novo acute myeloid leukemia.
Tang FF; Huang XJ; Zhang XH; Chen H; Chen YH; Han W; Chen Y; Wang FR; Wang Y; Wang JZ; Yan CH; Sun YQ; Mo XD; Liu KY; Xu LP
Leuk Res; 2016 Aug; 47():8-15. PubMed ID: 27239735
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic stem cell transplantation following relapse post autologous stem cell transplantation in adult patients with acute myeloid leukemia: A retrospective analysis of 537 patients from the Acute Leukemia Working Party of the EBMT.
Christopeit M; Labopin M; Gorin NC; Saraceni F; Passweg J; Forcade E; Maertens J; Van Lint MT; Bosi A; Niederwieser D; Ehninger G; Polge E; Mohty M; Nagler A
Am J Hematol; 2018 Dec; 93(12):1532-1542. PubMed ID: 30218444
[TBL] [Abstract][Full Text] [Related]
15. T-cell-depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: A study from the Acute Leukemia Working Party of the European Society of Blood and Marrow Transplantation (EBMT).
Sestili S; Labopin M; Ruggeri A; Velardi A; Ciceri F; Maertens J; Kanz L; Aversa F; Lewalle P; Bunjes D; Mohty M; Nagler A
Cancer; 2018 May; 124(10):2142-2150. PubMed ID: 29469924
[TBL] [Abstract][Full Text] [Related]
16. AlloHSCT for inv(3)(q21;q26)/t(3;3)(q21;q26) AML: a report from the acute leukemia working party of the European society for blood and marrow transplantation.
Halaburda K; Labopin M; Houhou M; Niederwieser D; Finke J; Volin L; Maertens J; Cornelissen JJ; Milpied N; Stuhler G; Kröger N; Esteve J; Mohty M; Nagler A
Bone Marrow Transplant; 2018 Jun; 53(6):683-691. PubMed ID: 29670208
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic Stem Cell Transplantation in Patients With FLT3-ITD Mutated AML: Transplantation in CR1 Is the Decisive Factor for Good Outcome.
Jindra P; Raida L; Karas M; Szotkowski T; Lysák D; Hrabětová M; Jungová A; Steinerová K; Faber E; Papajík T
Clin Lymphoma Myeloma Leuk; 2019 Jul; 19(7):462-469. PubMed ID: 31109905
[TBL] [Abstract][Full Text] [Related]
18. Secondary Acute Myeloid Leukemia (sAML): Similarly Dismal Outcomes of AML After an Antecedent Hematologic Disorder and Therapy Related AML.
Lalayanni C; Gavriilaki E; Athanasiadou A; Iskas M; Papathanasiou M; Marvaki A; Mpesikli S; Papaioannou G; Mallouri D; Batsis I; Papalexandri A; Sakellari I; Anagnostopoulos A
Clin Lymphoma Myeloma Leuk; 2022 Apr; 22(4):e233-e240. PubMed ID: 34756570
[TBL] [Abstract][Full Text] [Related]
19. Impact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow Transplantation.
Lucchini G; Labopin M; Beohou E; Dalissier A; Dalle JH; Cornish J; Zecca M; Samarasinghe S; Gibson B; Locatelli F; Bertrand Y; Abdel-Rahman F; Socie G; Sundin M; Lankester A; Sedlacek P; Hamladji RM; Heilmann C; Afanasyev B; Hough R; Peters C; Bader P; Veys P
Biol Blood Marrow Transplant; 2017 Mar; 23(3):467-474. PubMed ID: 27916512
[TBL] [Abstract][Full Text] [Related]
20. Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT study.
Baron F; Nagler A; Galimard JE; Sanz J; Versluis J; Forcade E; Chevallier P; Sirvent A; Anthias C; Kuball J; Furst S; Rambaldi A; Sierra J; von dem Borne PA; Gallego Hernanz MP; Cluzeau T; Robinson S; Raiola AM; Labussière-Wallet H; Byrne JL; Malfuson JV; Ruggeri A; Mohty M; Ciceri F
Br J Haematol; 2024 Jan; 204(1):250-259. PubMed ID: 37784256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
